Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab – incidence and predictors
暂无分享,去创建一个
H. Kantarjian | G. Borthakur | M. Keating | S. O'brien | F. Giles | W. Wierda | S. Lerner | J. Cortes | D. Thomas
[1] Manuel Solano-Genesta,et al. Alemtuzumab and Rituximab in the treatment of refractory autoimmune Cytopenias. , 2009 .
[2] Y. Ikeda,et al. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia. , 2006, Leukemia research.
[3] F. Ferrara,et al. Rituximab therapy for chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia , 2006, American journal of hematology.
[4] T. Hamblin. Autoimmune complications of chronic lymphocytic leukemia. , 2006, Seminars in oncology.
[5] M. Andreeff,et al. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] C. Craddock,et al. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation , 2005, Bone Marrow Transplantation.
[7] X. Mariette,et al. Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren’s syndrome , 2005, Annals of the rheumatic diseases.
[8] S. Tosti,et al. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment , 1992, Annals of Hematology.
[9] A. Mehta,et al. Rituximab in the treatment of refractory autoimmune cytopenias in adults. , 2005, Haematologica.
[10] D. Catovsky,et al. Incidence of Hemolytic Anemia after Chemotherapy in the CLL4 Trial. A Possible Protective Role for Fludarabine Plus Cyclophosphamide. , 2004 .
[11] A. Berrebi,et al. Intractable Autoimmune Hemolytic Anemia in B Cell Chronic Lymphocytic Leukemia Resolved by Rituximab , 2004, Leukemia & lymphoma.
[12] F. Shammas,et al. Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. , 2004, Blood.
[13] S. Paydaş. Fludarabine-induced hemolytic anemia: successful treatment by rituximab. , 2004, The hematology journal : the official journal of the European Haematology Association.
[14] D. Catovsky,et al. Classification of mature T-cell leukemias. , 2004, Leukemia.
[15] T. Shanafelt,et al. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. , 2003, Mayo Clinic proceedings.
[16] S. Schichman,et al. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma † , 2003, American journal of hematology.
[17] J. Sabio,et al. Salivary and serum beta2-microglobulin and gamma-glutamyl-transferase in patients with primary Sjögren syndrome and Sjögren syndrome secondary to systemic lupus erythematosus. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[18] P. Thall,et al. A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression , 2003, British journal of haematology.
[19] R. Fanin,et al. Anti-CD20 Therapy for Chronic Lymphocytic Leukemia-associated Autoimmune Diseases , 2003, Leukemia & lymphoma.
[20] A. Zanella,et al. In vitro production of anti‐RBC antibodies and cytokines in chronic lymphocytic leukemia , 2002, American journal of hematology.
[21] N Gupta,et al. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia , 2002, Leukemia.
[22] E. Iannitto,et al. Sustained response of refractory chronic lymphocytic leukemia in progression complicated by acute hemolitic anemia to anti-CD20 monoclonal antibody. , 2002, Blood.
[23] H. Ghazal. Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. , 2002, Blood.
[24] P. Feugier,et al. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. , 2001, Blood.
[25] M. Błasińska-Morawiec,et al. Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial. , 2000, Blood.
[26] R. Foà,et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. , 2000, Blood.
[27] G. Eberl,et al. Extracellular processing and presentation of a 69-mer synthetic polypetide to MHC class I-restricted T cells. , 1999, Molecular immunology.
[28] S. Molica,et al. Clinico‐prognostic implications of simultaneous increased serum levels of soluble CD23 and β2‐microglobulin in B‐cell chronic lymphocytic leukemia , 1999, European journal of haematology.
[29] E J Freireich,et al. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. , 1998, Blood.
[30] J. Byrd,et al. Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] L. Diehl,et al. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. , 1998, Seminars in oncology.
[32] G. Tchernia,et al. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia. , 1996, Hematology and cell therapy.
[33] M. Grever,et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.
[34] R. Soutar,et al. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. , 1996, British journal of haematology.
[35] A. Tedeschi,et al. Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia. , 1994, Leukemia & lymphoma.
[36] H. Kantarjian,et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. , 1993, Leukemia & lymphoma.
[37] H. Kantarjian,et al. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[39] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[40] D.,et al. Regression Models and Life-Tables , 2022 .